Procaps Group SA
General ticker "PROC" information:
- Sector: Health Care
- Industry: Pharmaceuticals
- Capitalization: $211.8M
Procaps Group SA does not follow the US Stock Market performance with the rate: -39.6%.
Estimated limits based on current volatility of 14.9%: low 2.53$, high 3.42$
Factors to consider:
- Earnings expected soon, date: 2024-12-24 bmo
- Current price 30.1% below estimated low
- Earnings for 12 months up through Q4 exceed our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2022-12-31 to 2024-12-30
- 2022-12-31 to 2023-12-31 estimated range: [4.34$, 7.38$]
- 2023-12-31 to 2024-12-30 estimated range: [3.78$, 6.56$]
Short-term PROC quotes
Long-term PROC plot with estimates
Financial data
| YTD | 2022-12-31 |
|---|---|
| Operating Revenue | $409.92MM |
| Operating Expenses | $357.60MM |
| Operating Income | $52.32MM |
| Non-Operating Income | $0.39MM |
| Interest Expense | $25.76MM |
| Income(Loss) | $52.71MM |
| Taxes | $10.17MM |
| Profit(Loss) | $42.54MM |
| Stockholders Equity | $-0.94MM |
| Inventory | $96.83MM |
| Assets | $460.19MM |
| Operating Cash Flow | $14.11MM |
| Capital expenditure | $31.57MM |
| Investing Cash Flow | $-28.83MM |
| Financing Cash Flow | $-13.63MM |
| Earnings Per Share* | $0.42 |
* EPS are Split Adjusted, recent splits may be reflected with a delay.